A number of Congressional committees have held hearings recently to address various health policy issues, including the following:

  • The House Energy and Commerce Committee conducted hearings on Medicare Part D drug policy, the role CMS contractors play in management of the Medicare program, and the public health threat of counterfeit drugs;
  • The House Education and the Workforce Committee held a hearing on “Providing Access to Affordable, Flexible Health Plans through Self-Insurance”;
  • A House Oversight and Government Reform Committee hearing examined the rights of FDA whistleblowers; and
  • A Senate Health, Education, Labor and Pensions Committee hearing focused on mental health treatment options and trends.